|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
8.35 Million
|
|
Market
Size (2030)
|
USD
21.79 Million
|
|
CAGR
(2025-2030)
|
17.29%
|
|
Fastest
Growing Segment
|
Standard
Chemotherapy
|
|
Largest
Market
|
Dubai
|
Market Overview
UAE Stomach Cancer Treatment Market was valued at USD
8.35 Million in 2024 and is expected to reach USD 21.79 Million with a CAGR of 17.29%
through 2030. The UAE Stomach Cancer Treatment Market is driven by a
combination of factors, including rising cancer awareness, advancements in
medical technology, and increasing healthcare infrastructure. With growing
awareness of the risks associated with stomach cancer and its symptoms, more
patients are seeking early diagnosis and treatment. As a result, there is an
increasing demand for innovative treatments and therapies that offer better outcomes.
The adoption of advanced treatment options such as targeted therapy,
immunotherapy, and minimally invasive surgical techniques is significantly
shaping the market. These therapies offer more precise treatments with fewer
side effects, leading to better patient outcomes. The availability of
state-of-the-art diagnostic tools, such as endoscopic ultrasound (EUS) and
advanced imaging technologies, is also facilitating earlier detection,
contributing to a more effective treatment approach. The UAE's ongoing
healthcare investments, including the establishment of specialized cancer
treatment centers and hospitals, are providing patients with greater access to
cutting-edge treatments. The UAE's position as a medical hub in the Middle East
also attracts patients from surrounding regions, further boosting demand for
stomach cancer treatments.
Key Market Drivers
Rising Incidence of Stomach Cancer
The rising incidence of stomach cancer in the UAE
is a major factor driving the growth of the Stomach Cancer Treatment Market. As
lifestyle-related diseases become more prevalent, especially in the urbanized
segments of the population, the number of individuals diagnosed with stomach
cancer is steadily increasing. Several factors contribute to this surge in cases,
including unhealthy dietary habits, increased consumption of processed foods,
high salt intake, smoking, alcohol consumption, and sedentary lifestyles. In
addition, the aging population in the UAE further exacerbates this trend, as
the risk of stomach cancer increases with age. Gastric cancer is the fifth
leading cause of cancer-related deaths in the UAE, accounting for an estimated
4.31% of cancer fatalities, which is lower compared to global statistics.
Despite its prevalence, gastric cancer in the UAE is generally considered less
fatal. In 2021, the crude incidence rate of gastric cancer in the UAE was 1.4
per 100,000 people, which is lower than the global crude incidence rate.
However, the high mortality rate in the UAE is attributed to the advanced stage
at which the disease is typically diagnosed.
The increase in stomach cancer cases has led to a
higher demand for early detection, diagnosis, and effective treatment options.
As more individuals seek medical attention for symptoms related to the disease,
there is a growing need for advanced diagnostic technologies and treatment
therapies. The UAE's healthcare system is evolving to meet this demand by
investing in the latest diagnostic tools and treatment methodologies. From
early-stage screenings to advanced therapies such as chemotherapy, immunotherapy,
and minimally invasive surgeries, the market is witnessing a significant push
to cater to the increasing number of cancer cases. The government's focus on
reducing the burden of cancer and offering better treatment options has
accelerated the growth of the treatment market, ensuring that patients have
access to life-saving medical interventions.
Advancements in Medical Technology
Advancements in medical technology are
revolutionizing the UAE Stomach Cancer Treatment Market, making it one of the
most dynamic sectors in healthcare. Breakthroughs in diagnostic imaging
techniques such as endoscopic ultrasound (EUS), computed tomography (CT) scans,
and magnetic resonance imaging (MRI) have dramatically improved the accuracy of
stomach cancer diagnosis, enabling early detection and timely intervention.
These innovations allow for non-invasive visualization of tumors and detection
of abnormal growths in the stomach lining, aiding in the identification of the
disease in its early stages when treatment outcomes are more favorable. In
September 2021, The Surgical Equipment Unit team of Zahrwai Group hosted a highly
successful hybrid seminar for oncology doctors titled “The Role of PIPAC in
Colorectal, Gastric, and Ovarian Malignancies” at Mediclinic Parkview Hospital
in Dubai. The seminar focused on PIPAC (Pressurized Intra-Peritoneal Aerosol
Chemotherapy), a groundbreaking treatment technique. PIPAC is a minimally invasive method that delivers
chemotherapy directly into the abdomen under pressure via small 1cm ports. This
approach is used to treat advanced, inoperable cancers of the stomach, colon,
end-stage peritoneal carcinomatosis, and ovaries, offering a new treatment
option for patients with these challenging conditions.
Minimally invasive surgery and robotic-assisted
surgeries are becoming more common in the UAE, offering patients quicker
recovery times, fewer complications, and enhanced precision during surgery.
These procedures allow surgeons to remove tumors with minimal damage to
surrounding tissues, preserving the patient's overall health and quality of
life. The integration of Artificial Intelligence (AI) in treatment planning and
diagnostic procedures is enabling highly personalized care for patients.
AI-driven algorithms help in predicting tumor growth, determining optimal
treatment regimens, and assisting clinicians in making more accurate diagnostic
decisions. The combination of these technological advancements has led to more
efficient, effective, and patient-friendly treatment options for stomach
cancer, driving growth in the market.
Rising Healthcare Awareness
Increased public awareness of stomach cancer in the
UAE is playing a crucial role in the growing demand for timely diagnosis and treatment.
Over the years, the government, healthcare organizations, and non-profit
institutions have launched numerous awareness campaigns aimed at educating the
public about the risk factors, symptoms, and importance of early detection of
stomach cancer. With rising knowledge about lifestyle-related risk factors such
as poor diet, smoking, and alcohol consumption, people in the UAE are becoming
more proactive in seeking medical consultations and participating in
screenings.
The availability of educational materials,
informational seminars, and advertisements has contributed to a growing
understanding of the importance of early intervention in the treatment of
stomach cancer. As a result, more individuals are opting for regular check-ups,
especially those who may be at high risk due to their family history or
lifestyle choices. This shift toward preventive healthcare and early detection
has a direct impact on the demand for stomach cancer treatment, as early
detection ensures better treatment outcomes and reduces the burden on
healthcare systems. As the public becomes more engaged with their health, the
overall demand for stomach cancer diagnosis and treatment continues to rise,
further fueling the market’s growth.
Improved Healthcare Infrastructure
The UAE has made substantial investments in its
healthcare infrastructure in recent years, which has been a critical driver of
the growth of the Stomach Cancer Treatment Market. The country's healthcare
system is recognized for its high standards, modern facilities, and access to
cutting-edge technologies. With continuous upgrades to hospital facilities,
diagnostic centers, and cancer treatment centers, patients in the UAE have
access to the latest medical advancements and specialized care.
State-of-the-art hospitals and cancer treatment
centers, particularly in major cities like Dubai and Abu Dhabi, offer
comprehensive services for the diagnosis and treatment of stomach cancer. These
hospitals are equipped with the latest diagnostic imaging technologies, as well
as advanced treatment options such as targeted therapies, chemotherapy, and
immunotherapy. The government’s commitment to expanding healthcare facilities
and providing high-quality care has also played a significant role in improving
access to healthcare services for the population. The UAE has witnessed an
influx of medical tourists from neighboring regions, further pushing the demand
for specialized cancer treatment services. This influx is further driving
investments in healthcare infrastructure, allowing for more specialized centers
for stomach cancer treatment. The continuous development of healthcare
infrastructure is a key enabler for the growth of the Stomach Cancer Treatment
Market, ensuring that the country remains at the forefront of cancer care in
the region.
Download Free Sample Report
Key Market Challenges
High Cost of Treatment and Healthcare Services
One of the major challenges facing the UAE Stomach
Cancer Treatment Market is the high cost of treatment. Advanced treatments such
as chemotherapy, targeted therapies, immunotherapies, and surgeries often come
with significant expenses. These costs can be a barrier to access for many
individuals, especially those without sufficient insurance coverage. The
United Arab Emirates is ranked 26th in the 2024 World Index of Healthcare
Innovation, a drop from its 19th position in 2022.
While the UAE government has implemented health
insurance schemes to cover medical expenses, not all treatments, especially
newer and experimental therapies, may be included in basic insurance packages.
This financial strain can prevent many patients from seeking timely medical
intervention or opting for the most advanced forms of treatment available. Medical
tourism in the UAE also drives up the cost of healthcare services, as many
people from neighboring countries seek treatment in the UAE's advanced healthcare
facilities. This demand further increases the prices, making healthcare less
affordable for local residents.
The healthcare system in the UAE is heavily reliant
on private healthcare providers, which tend to charge higher fees than public
institutions. While many of the top hospitals in the UAE are equipped with
state-of-the-art technology and qualified professionals, the treatment cost in
these facilities is often higher than in countries with more affordable
healthcare systems. The combination of high demand for quality services,
reliance on advanced treatments, and the need for continuous investments in
infrastructure and technology further strains the affordability and
accessibility of stomach cancer treatment for some segments of the population.
Limited Awareness and Early Detection Challenges
Although there is growing awareness of stomach
cancer, it remains a significant challenge in the UAE. Stomach cancer,
particularly in its early stages, often presents few or no symptoms, making
early detection difficult. Many individuals may not seek medical attention
until the disease has reached an advanced stage, when treatment options become
limited and less effective. This delay in diagnosis contributes to lower
survival rates and complicates treatment efforts.
Despite government and non-governmental initiatives
to increase cancer awareness, general public knowledge regarding stomach cancer
symptoms, risk factors, and the importance of regular screenings remains
insufficient. There is also a lack of widespread screening programs targeting
high-risk individuals in the population, which is essential for early
detection. While some hospitals and clinics offer screening services, they are
often not widely accessible to all populations, particularly those in rural or
less-developed areas. This is due to the limited availability of specialized
diagnostic tools and a shortage of skilled medical professionals in certain
regions of the UAE.
The lack of early-stage detection and awareness
further exacerbates the challenge of stomach cancer treatment, as early
intervention is crucial to improving patient outcomes. A more concerted effort
from both public and private healthcare organizations is required to promote
regular screening programs, educate the public on risk factors, and increase
awareness about the early signs of stomach cancer. This will help to address
the challenges associated with diagnosis and improve the prognosis for patients.
Key Market Trends
Government Initiatives and Support
The UAE government plays a vital role in supporting
the healthcare sector and, by extension, the stomach cancer treatment market.
The government’s efforts to enhance healthcare facilities, invest in cancer
research, and implement national cancer awareness programs contribute to market
growth. Initiatives like free screenings, medical insurance coverage, and
specialized cancer treatment centers help make treatment more accessible and
affordable for a broader population, thus driving the demand for stomach cancer
treatment services.
Medical Tourism
The UAE has firmly established itself as a premier
hub for medical tourism, making it a key destination for patients seeking
high-quality healthcare services, including stomach cancer treatments. With its
world-class medical facilities, cutting-edge technologies, and internationally
recognized healthcare professionals, the UAE offers patients from neighboring
countries and further regions access to state-of-the-art treatment options that
may not be readily available in their home countries. A significant factor
contributing to the UAE's appeal as a medical tourism destination is the
country’s healthcare infrastructure. The UAE boasts a range of modern hospitals
and cancer treatment centers equipped with the latest diagnostic tools and
therapeutic technologies. These facilities are staffed by highly trained
professionals, many of whom have received training and certification from
internationally renowned institutions. These professionals bring a wealth of
expertise in diagnosing and treating complex conditions like stomach cancer,
ensuring that patients receive the highest level of care.
The availability of advanced treatments such as
robotic-assisted surgery, minimally invasive procedures, targeted therapies,
and immunotherapy plays a key role in attracting patients seeking effective and
cutting-edge treatments for stomach cancer. The rapid advancements in medical
technology, combined with the UAE's growing reputation for providing
world-class medical services, have made it a preferred choice for individuals
seeking life-saving treatments. In many cases, patients traveling to the UAE for
cancer treatment benefit from a comprehensive treatment approach that
integrates the latest medical innovations with personalized care, leading to
better outcomes.
Segmental Insights
Treatment Type Insights
Based on the Treatment Type,
Standard Chemotherapy remains the dominant therapy in the market. This
treatment approach, which uses drugs to kill or slow the growth of cancer
cells, is widely used due to its long-standing history of effectiveness in
treating various cancers, including stomach cancer. Chemotherapy is often used
in combination with other treatments such as surgery or radiation therapy to
manage the disease at different stages.
One key reason for the
dominance of chemotherapy in the UAE Stomach Cancer Treatment Market is its
established presence in healthcare systems globally. It is a standard practice
for oncologists to recommend chemotherapy as the first line of defense against
stomach cancer, particularly for patients diagnosed with advanced or metastatic
stages of the disease. Chemotherapy is also considered effective for patients
who are not eligible for surgery, as it can shrink tumors, ease symptoms, and
extend survival. In the UAE, hospitals and cancer treatment centers are
equipped with the latest chemotherapy drugs and protocols that are closely
monitored for effectiveness and safety. The availability of these therapies in
both private and public healthcare sectors, along with well-trained
oncologists, ensures that chemotherapy continues to be the go-to treatment
option. Many healthcare providers in the UAE offer a range of supportive
treatments to manage the side effects of chemotherapy, enhancing its
tolerability for patients.
Disease Indication Insights
Based on the Disease
Indication, Gastric Cancer/Gastroesophageal Junction Cancer is currently the
dominant type of cancer in the UAE Stomach Cancer Treatment Market. Gastric
cancer, which refers to cancer that originates in the stomach lining, and
gastroesophageal junction (GEJ) cancer, which occurs at the junction of the
stomach and esophagus, are the primary focus of most stomach cancer treatments
in the UAE. These types of cancers account for the majority of cases seen in
hospitals and cancer centers across the country, largely due to lifestyle and
dietary factors that increase the risk of developing gastric cancer, such as
high salt intake, smoking, and a family history of the disease. Gastric
cancer in the UAE is considered less lethal. The GC's crude incidence rate in
the UAE in 2021 was 1.4 per 100,000, which is lower than the global incidence
crude rate.
The higher prevalence of
gastric cancer and gastroesophageal junction cancer in the UAE is directly
reflected in the treatment market, which is geared towards addressing these
specific forms of cancer. The UAE healthcare system has developed specialized treatment
programs for gastric cancer patients, incorporating a combination of surgery,
chemotherapy, targeted therapy, and immunotherapy, depending on the cancer's
stage and progression. Surgical options, particularly for early-stage gastric
cancer, have been instrumental in improving patient outcomes, while
chemotherapy remains the primary line of treatment for advanced stages. The
availability of advanced diagnostics and imaging systems, such as endoscopy and
CT scans, has contributed to the early detection and treatment of these
cancers, further driving the demand for effective treatment options.
Download Free Sample Report
Regional Insights
Dubai was dominating the UAE Stomach
Cancer Treatment Market. As the largest and most populous city in the UAE,
Dubai serves as the country’s healthcare hub, drawing patients both locally and
from neighboring countries seeking advanced cancer treatments. The city boasts
state-of-the-art medical infrastructure, including world-class hospitals,
specialized cancer treatment centers, and cutting-edge technology that play a
crucial role in diagnosing and treating stomach cancer. Dubai’s focus on healthcare
innovation, driven by its commitment to becoming a global medical tourism
destination, further solidifies its position as the leader in this market.
Dubai’s healthcare system has attracted renowned
international medical professionals and experts in oncology, making it a key
center for high-quality, specialized stomach cancer treatments. Many hospitals
and medical centers in Dubai offer a comprehensive range of treatment options,
such as surgery, chemotherapy, targeted therapy, and immunotherapy. The
concentration of specialized cancer centers in the city, alongside a
well-established healthcare infrastructure, enables effective and timely care
for stomach cancer patients. The city’s medical tourism sector also contributes
significantly to the demand for advanced stomach cancer treatments, as patients
from the Middle East, North Africa, and other regions often travel to Dubai for
world-class healthcare services.
Dubai’s strong focus on research and development in
the medical field allows the continuous introduction of advanced treatment
modalities, improving the prognosis for stomach cancer patients. This includes
cutting-edge technologies like robotic-assisted surgeries, minimally invasive
procedures, and Artificial Intelligence-based diagnostic tools. The
availability of these innovations strengthens Dubai’s dominance in the UAE
Stomach Cancer Treatment Market.
Recent Developments
- In June 2023, AstraZeneca introduced its
groundbreaking cancer medication, IMJUDO® (tremelimumab), in the UAE. This launch positions the UAE as one of the first
countries in the Middle East to offer access to this innovative treatment,
marking a major step forward in cancer therapy. Clinical trials have shown that
IMJUDO® is both effective and well-tolerated when used in combination with
treatments for various cancer types, including metastatic non-small cell lung
cancer and hepatobiliary cancers. The medication has demonstrated promising
results in prolonging progression-free survival and overall survival rates,
providing patients with improved treatment outcomes and enhancing their quality
of life.
- In July 2024, the groundbreaking ceremony for Asan
GI Hospital-UAE (tentative name), the inaugural international hospital of Asan
Medical Center and the first specialized gastrointestinal hospital in the Gulf
Cooperation Council (GCC) region, took place on July 10 at Dubai Healthcare
City Phase 2. This initiative is designed to improve the quality of life for
critically ill patients in the Middle East and elevate local healthcare
standards by providing advanced treatments for gastrointestinal cancers, including
stomach and colon cancer, post-liver transplantation care, bariatric surgery,
and pediatric digestive diseases.
- In June 2023, AstraZeneca launched its innovative
cancer treatment, IMJUDO® (tremelimumab), in the UAE, making it one of the
first countries in the Middle East to offer this breakthrough in cancer
therapy. Clinical trials have shown that IMJUDO® is both effective and
well-tolerated when used in combination with treatments for various types of
cancer, including metastatic non-small cell lung cancer and hepatobiliary
cancers. The drug has demonstrated promising results in extending
progression-free survival and improving overall survival rates, leading to
better treatment outcomes and an enhanced quality of life for patients.
- In February 2023, Sonrai Analytics, a health-tech
company from Northern Ireland, partnered with Alliance Care Technologies (ACT),
a UAE-based firm, to expand its AI technologies in the region.
Key Market Players
- Thermo Fisher Scientific
Middle East
- Bristol Myers Squibb, Middle
East & Africa FZ-LLC
- Illumina Dubai Middle East FZE
- Roche Diagnostics Middle East
FZCO
- Gulf Bio Analytical LLC
- Abbott Laboratories S.A.
- Hitachi Ltd.
- Gulf International Cancer
Center
- Pfizer Gulf FZ LLC
- AstraGene LLC
|
By Treatment
Type
|
By Disease
Indication
|
By Route Of
Administration
|
By Drug
Class
|
By Region
|
- Standard
Chemotherapy
- Targeted
Therapy
- Immunotherapy
|
- Gastric cancer/Gastroesophageal
Junction cancer
- Gastrointestinal
Stromal Tumours
|
|
- PD-1/PD-L1
Inhibitors
- HER2
Antagonists
- VEGFR
Antagonists
- Others
|
- Abu Dhabi
- Dubai
- Sharjah
- Rest of UAE
|
Report Scope:
In this report, the UAE Stomach Cancer Treatment
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- UAE Stomach Cancer Treatment Market, By Treatment Type:
o Standard Chemotherapy
o Targeted Therapy
o Immunotherapy
- UAE Stomach Cancer Treatment Market, By Disease Indication:
o Gastric cancer/Gastroesophageal Junction cancer
o Gastrointestinal Stromal Tumours
- UAE Stomach Cancer Treatment Market, By Route Of Administration:
o Oral
o Injectable
- UAE Stomach Cancer Treatment Market, By Drug Class:
o PD-1/PD-L1 Inhibitors
o HER2 Antagonists
o VEGFR Antagonists
o Others
- UAE Stomach Cancer Treatment Market, By
Region:
o Abu Dhabi
o Dubai
o Sharjah
o Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the UAE Stomach
Cancer Treatment Market.
Available Customizations:
UAE Stomach Cancer Treatment Market report with
the given market data, TechSci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
UAE Stomach Cancer Treatment Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at [email protected]m